{"id":"W2287184838","doi":"10.1200/jco.2007.25.18_suppl.7539","title":"Gemcitabine/platinum alone or in combination with cetuximab as first-line treatment for advanced non-small cell lung cancer (NSCLC)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Bristol-Myers Squibb (Canada); Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Gemcitabine; Cetuximab; Carboplatin; Internal medicine; Regimen; Lung cancer; Clinical endpoint; Chemotherapy; Pleural effusion; Oncology; Chemotherapy regimen; Progression-free survival; Phases of clinical research; Gastroenterology; Cisplatin; Urology; Cancer; Randomized controlled trial; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009566944,0.0007976636,0.001428919,0.0005941732,0.0002760871,0.0004765111,0.0005434187,0.0008913467,0.002809181],"category_scores_gemma":[0.0006357239,0.0003998982,0.0006448086,0.000441311,0.0005267311,0.0003924172,0.0003417903,0.001443422,0.0004241107],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005598355,"about_ca_system_score_gemma":0.0008566864,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000862272,"about_ca_topic_score_gemma":0.00430117,"domain_scores_codex":[0.9997019,0.0001468227,0.00002614951,0.00004021188,0.00002913538,0.00005588822],"domain_scores_gemma":[0.9996325,0.00006715874,0.00007584745,0.00001435068,0.00001068015,0.000199525],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7391627,0.03507857,0.009681166,0.001850668,0.002457618,0.0004606379,0.000166321,0.003426223,0.03879206,0.0002290196,0.00352948,0.1651656],"study_design_scores_gemma":[0.5211712,0.4402404,0.0237473,0.0001579088,0.001529867,0.000417075,0.00004180516,0.001925815,0.006599976,0.0001729583,0.003957611,0.00003812242],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930758,0.003650589,0.0002214682,0.0002965398,0.00015492,0.001007479,0.0002732189,0.00005211432,0.001267817],"genre_scores_gemma":[0.9948853,0.002053004,0.0007609311,0.0004063486,0.0001578214,0.0005546589,0.0003288553,0.000007051331,0.000845966],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002809181,"threshold_uncertainty_score":0.009397626,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06046833552443279,"score_gpt":0.481034280150909,"score_spread":0.4205659446264762,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}